Annals of Emergency Medicine
Volume 54, Issue 3 , Pages 339-341 , September 2009

Thrombolysis in Stroke: Still Not Ready for Community Hospital Use by Emergency Physicians

  • Robert M. McNamara, MD

      Affiliations

    • Corresponding Author InformationAddress for correspondence: Robert M. McNamara, MD, Department of Emergency Medicine, Temple University School of Medicine, 10th Floor Jones Hall, 3410 North Broad St, Philadelphia, PA 19140; 215-707-5030, Fax 215-707-3494

References 

  1. Hoffman JR, Schriger DL. A graphical reanalysis of the NINDS trial. Ann Emerg Med. 2009;54:329–336
  2. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581–1587
  3. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317–1329
  4. Lyden P. Thrombolytic therapy for acute stroke: not a moment to lose. N Engl J Med. 2008;359:1393–1395
  5. Weintraub MI. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire. Stroke. 2006;37:1917–1922
  6. Hertzberg V, Ingall T, O'Fallon W, et al. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial. Clin Trials. 2008;5:308–315
  7. Lindley RI. Commentary on NICE guidelines for alteplase for the treatment of acute ischaemic stroke. Heart. 2007;93:1617–1618
  8. Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2003;(3)::CD000213.
  9. Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005;172:1307–1312
  10. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007;369:275–282
  11. Bravata DM, Kim N, Concato J, et al. Thrombolysis for acute stroke in routine clinical practice. Arch Intern Med. 2002;162:1994–2001
  12. Deng YZ, Reeves MJ, Jacobs BS, et al. IV tissue plasminogen activator use in acute stroke (Experience from a statewide registry). Neurology. 2006;66:306–312
  13. Dubinsky R, Lai S. Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample. Neurology. 2006;66:1742–1744
  14. Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice (A meta-analysis of safety data). Stroke. 2003;34:2847–2850
  15. Jenkins PO, Turner MR, Jenkins PF. What is the place of thrombolysis in acute stroke? (a review of the literature and a current perspective). Clin Med. 2008;8:253–258
  16. Brown DL, Barsan WG, Lisabeth LD, et al. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Ann Emerg Med. 2005;46:56–60
  17. Libman RB, Wirkowski E, Alvir J, et al. Conditions that mimic stroke in the emergency department (Implications for acute stroke trials). Arch Neurol. 1995;52:1119–1122
  18. Mecozzi AC, Brown DL, Lisabeth LD, et al. Determining intravenous rt-PA eligibility in the emergency department. Neurocrit Care. 2007;7:103–108
  19. Akins PT, Delemos C, Wentworth D, et al. Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke?. Neurology. 2000;55:1801–1805

 Supervising editor: Donald M. Yealy, MD

 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article that might create any potential conflict of interest. The author has stated that no such relationships exist. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement.

 Reprints not available from the author.

PII: S0196-0644(09)01135-4

doi: 10.1016/j.annemergmed.2009.06.504

Annals of Emergency Medicine
Volume 54, Issue 3 , Pages 339-341 , September 2009

Article Tools